3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
51
Colorectal Neoplasms
44
Carcinoma, Hepatocellular
36
Rectal Neoplasms
26
Lung Neoplasms
23
Colonic Neoplasms
22
Neoplasm Metastasis
18
Esophageal Neoplasms
18
Cholangiocarcinoma
15
Breast Neoplasms
13
Stomach Neoplasms
12
Glioma
11
Ovarian Neoplasms
10
Melanoma
10
Carcinoma, Non-Small-Cell Lung
10
Carcinoma, Renal Cell
9
Anus Neoplasms
9
Sarcoma
8
Uterine Cervical Neoplasms
7
Prostatic Neoplasms
7
Medulloblastoma
7
Lymphoma, Non-Hodgkin
7
Ependymoma
7
Carcinoma, Transitional Cell
7
Brain Neoplasms
7
Adenocarcinoma Of Esophagus
7
Wilms Tumor
6
Rhabdomyosarcoma
6
Rhabdoid Tumor
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Interventions
Cyclophosphamide
4
pembrolizumab
3
Nivolumab
3
regorafenib
2
fludarabine
2
SS1(dsFv)PE38
2
Ipilimumab
2
Hyperthermic Intraperitoneal Chemotherapy
2
Doxorubicin
2
Decitabine
2
Cisplatin
2
tislelizumab
1
sodium thiosulfate
1
sargramostim
1
entinostat
1
durvalumab
1
cemiplimab
1
bemcentinib
1
avelumab
1
atezolizumab
1
alvocidib
1
alanosine
1
X-Rays
1
Tetrahydrouridine
1
Tamoxifen
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Magnetic Resonance Spectroscopy
×
Gastrointestinal
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled